73 Followers on Owler

Aura

is a Massachusetts-based clinical-stage biotechnology company that researches and develops viral nanoparticle conjugate therapies for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights

Aura

is a Massachusetts-based clinical-stage biotechnology company that researches and develops viral nanoparticle conjugate therapies for the treatment of cancer... Read more
Aura President & CEO: Natalie Holles

President & CEO

Natalie Holles

CEO Approval Rating

- -/100

2009

PublicNASDAQAURA

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
<$1M
Employees
50
Funding
$751.4M

News

Leadership Change
Jul 08, 2026
GlobalNewswire
Jeremy Bender joined Aura as Board of Director
Funding
May 06, 2026
GlobeNewswire
Aura received $299.4M in Post-IPO Equity Funding

Aura Competitors

1ImmunityBio
2UroGen
3CG Oncology
4Sesen Bio
5FerGene
6TScan
7Tmunity
8Dynavax
9NexImmune
10VelosBio
Unlock 10 + competitors

Trending Companies